Fulfilling two of the Company’s goals for 2021, Polymer Factory has signed a contract for a second lab to be used for analytical materials. In relation to this, the Company has also invested in a MALDI-TOF mass spectrometry (MS) instrument.
In August 2021, Polymer Factory will expand its premises to include a second lab to be used for its analytical materials segment. This is in line with the overall strengthening of the analytical materials segment, and the previous communication that a new Product Manager will join the team to head the segment.
Fulfilling yet another goal, the Company has also invested in a MALDI-TOF MS instrument that will be placed in the new lab. This investment, together with the new lab, will enable a greater focus on the development of Polymer Factory’s SpheriCal® platform and more.
About Polymer Factory
Polymer Factory was founded in 2006 at KTH Royal Institute of Technology and its Board of Directors have been essential in driving dendritic nanotechnology research to commercialization for almost 15 years – expertise that has been transferred to the Company’s products. Emerging from many years of cutting-edge research within the field, Polymer Factory today has, in the Company’s assessment, the world’s largest product portfolio of dendritic materials with customers ranging from Big Pharma, MedTech and BioTech companies, to research-intensive institutes and academic research groups. Polymer Factory has also used the Company’s vast knowledge and expertise to develop a patented calibration technology, named SpheriCal®, designed for Mass Spectrometry instruments.
For more information, please contact:
Elin Mignérus, CEO
Phone: +46 (0) 79 300 27 76
E-mail: elin.mignerus@polymerfactory.com
Find the press release HERE: